Viamet Pharmaceuticals' Partnership

Viamet Pharmaceuticals raised a round of funding on February 15, 2010. Investors include Novartis.

Viamet Pharmaceuticals discovers and develops breakthrough therapies based on specialization in metalloenzyme chemistry and biology. The company's clinical portfolio includes novel agents to treat bot…

Articles about Viamet Pharmaceuticals' Partnership: